Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation), By Applic
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationCell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation), By Applic
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 4.03 Billion |
| CAGR (2023-2028) | 13.04% |
| Fastest Growing Segment | Cancer Research |
| Largest Market | North America |
Market Overview
Global Cell Isolation Market has valued at USD 4.03 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 13.04% through 2028. Cell isolation, also known as cell isolation, refers to the process of identifying and removing specific cells from a heterogeneous mixture of cell population. These targeted cells are identified, isolated, and separated based on their cell type. Some commonly utilized methods for cell isolation include magnet-activated cell isolation, filtration, centrifugation, and flow cytometry. Cell isolation plays a vital role in diagnosing diseases, conducting cellular research, and developing therapies by analyzing ribonucleic acid (RNA) expressions. It helps simplify the experimental analysis of cells and reduces interference from other cell types within the sample. Consequently, it has extensive applications in cancer research, stem cell biology, immunology, and neurology. An example of an innovative technique that utilizes isolated cells is patch-clamp electrophysiology, which examines the movement of energized particles across the cell membrane. Isolated cells are also instrumental in cell culture, where a single cell multiplies to form a colony of cells. Moreover, cell isolation can be employed in various treatments. For instance, the isolation of pancreatic islet cells, followed by their culture and transplantation, has been performed to treat patients with Type 1 Diabetes.
Key Market Drivers
Increasing Prevalence of Chronic Diseases
The growing incidence of chronic diseases, such as diabetes and cancer, has led to an increased demand for cell-based therapies. Additionally, cell isolation plays a crucial role in various diagnostic experiments and research on chronic diseases. In drug discovery, cell isolation is essential for studying cellular behavior, disease response, and drug impact. Cell isolation tools are increasingly utilized in drug discovery techniques to develop recombinant protein therapeutics for treating a wide range of diseases, including cancer, autoimmune disorders, and genetic conditions. The global prevalence of chronic diseases has further amplified the applications of isolated human cells in research, drug development, and clinical trials. Therefore, the rising demand for cell-based therapies, driven by the growing incidence of chronic diseases, has resulted in an increased need for cell isolation tools.
The growth of chronic diseases, such as diabetes, obesity, arthritis, heart disorders, and cancer, is influenced by factors like increased sedentary lifestyle, global population aging, and higher rates of cigarette smoking and alcohol consumption. According to Imperial College London, chronic illnesses were projected to account for over 70% of global fatalities in 2020, with more than 41 million deaths annually. Approximately 17 million of these deaths are considered premature, occurring at a younger age than expected.
Rapid Increase in The Research Activities In The Pharmaceutical And Biotechnological Industries
The robust growth of the Cell Isolation/Cell isolation Market can be attributed to the significant increase in research activities within the pharmaceutical and biotechnological industries. This surge is in response to the rapid rise in the number of diseases, as well as the presence of well-developed infrastructures and advancements in technology. These factors contribute to the need for effective cell isolation and separation techniques, which further drives the market growth.
Government’s Policies to Enhance Biomedical Research Activities
In recent years, there has been a remarkable surge in initiatives and policies implemented by governments worldwide to support and promote biomedical research activities. This is primarily driven by the increasing awareness among customers about the significance of such research, as well as the growing number of aging population and the rising prevalence of chronic diseases. Consequently, the Cell Isolation Market has experienced a rapid growth trajectory.
Demand For Clinical Trials and Research Is Increasing As The Geriatric Population Grows
The senior population, comprising individuals aged 65 and over, is more prone to chronic illnesses such as cancer and neurological disorders when compared to the younger population. Notably, the geriatric population is experiencing rapid growth, which further magnifies the significance of addressing these health concerns. With the increasing number of individuals aged 65 and over, the prevalence of conditions like Alzheimer's, dementia, cancer, and immunological illnesses is expected to rise significantly.
Consequently, there will be an escalating demand for corrective treatments to cater to these conditions. This surge in demand is also projected to extend to the field of cell isolation products, which play a crucial role in various research endeavors, including clinical trials. As a result, the global market for cell isolation technologies is anticipated to witness substantial growth, driven by these factors.
Key Market Challenges
Lack of Technically Skilled Individuals
The shortage of technically competent workers in the field, coupled with the increasing concerns about the existence of tight rules and compliances for cell separation procedures, are projected to restrain the overall market expansion. Moreover, the high cost associated with cell separation technology implant treatments can potentially pose a significant threat to the growth of the market in the coming years. These factors highlight the need for strategic measures and innovative solutions to overcome these challenges and foster sustainable market growth.
Shift From Lab-Based Diagnosis to Home-Based Testing
The shift from lab-based diagnosis to home-based testing, driven by increased customer awareness, has led to a decrease in the chances of complications and significant advancements in technology. As a result, the growth of the Cell Isolation/Cell Separation Market is anticipated to be reduced. Additionally, the market growth may be hampered by the high costs associated with service contracts and raw materials. These factors collectively contribute to the challenges faced by the Cell Isolation Market, emphasizing the need for strategic solutions to address these concerns and ensure sustained growth in the industry.
Key Market Trends
Technological Advancement
It is anticipated that the cell separation technology market will experience significant growth opportunities in the coming years. This can be attributed to the rapid technological advancements in cell-based technology, such as higher purity yield and reduced cell isolation time. Additionally, the rise in government initiatives to improve cell-based technology and the cost-effectiveness of cell separation techniques are expected to contribute to market growth. Furthermore, the well-developed healthcare infrastructure in developing countries provides a favorable environment for the adoption and implementation of cell separation technologies. All these factors combined make the cell separation technology market poised for substantial expansion in the foreseeable future.
Product Innovations
The growth of the global cell isolation market is being fueled by advancements in the product offerings. Product innovations in this market are primarily driven by the increasing demand for automated tools in cell-based research for various chronic and infectious diseases. Key players in the market, such as BD and QIAGEN, are dedicated to continuous product improvement. For instance, in March 2019, BD launched the BD FACSDuet automated flow cytometry system, a fully automated sample preparation instrument that enhances the efficiency of clinical laboratories by minimizing errors and reducing the need for manual user interactions when running assays on the BD FACSLyric clinical flow cytometer. Other vendors, like Bio-Rad, are focused on the development of reagents for flow cytometry. In November 2020, Bio-Rad Laboratories, Inc. launched StarBright Blue 700, StarBright Violet 440, and StarBright Violet 610 dyes, which provide maximum brightness and improved resolution for flow cytometry. Hence, the continuous product advancements by established market players drive market growth and contribute to increased sales of these products.
Segmental Insights
Cell Type
Based on the cell type, the market is segmented into human cells and animal cells. In 2022, the human cell category emerged as the leader in terms of revenue share. This can be attributed to the growing emphasis on cancer and human research, as well as the wide range of applications of isolated human cells in biopharmaceutical development, clinical trials, and research. Moreover, the attractive payment policies for personalized medicine in industrialized countries further contribute to the demand for human cell isolation. It is projected that the animal cells segment will also witness profitable growth during the forecast period. The development of novel drugs has garnered significant attention from government bodies, the commercial sector, and healthcare organizations, thereby driving the growth of this segment. Animal cells play a crucial role in the discovery and development of new drugs, enabling the assessment of toxicity, pharmacokinetics, and effectiveness.
Technique Insights
Based on the technique segment, the market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment, accounted for the largest revenue share in 2022, has been a dominant force in the cell separation market. This technique is widely utilized by academic institutions, research centers, and biotechnology/biopharmaceutical companies. Centrifugation plays a crucial role in cell isolation, with both differential centrifugation and density gradient centrifugation commonly employed. Density gradient centrifugation leverages molecular weights for particle separation, while differential centrifugation employs lysates to disrupt cell membranes.
Looking ahead, significant growth is expected in both the surface marking and filtration segments. This market expansion is primarily driven by product development and increased corporate investments in manufacturing infrastructure. Manufacturers utilize innovative surface markers and filtration systems in their production and research processes to enhance the quality of the final product.
Regional Insights
The North American market is poised to lead the global cell isolation industry in the coming years, driven by the increasing prevalence of chronic diseases, growing demand for personalized medicine, and government funding for cell-based research and development. With its advanced healthcare system, robust research and development sector, and increasing investment in biotechnology research, North America is expected to witness the most significant revenue growth.
Asia Pacific is anticipated to experience rapid expansion in the cell isolation market due to factors such as escalating healthcare costs, a large patient base, and growing interest in cutting-edge cell separation methods. The region boasts several emerging nations, including China and India, where the incidence of chronic diseases is on the rise. Additionally, the accessibility to skilled personnel and affordable production costs is expected to attract numerous major players in the cell isolation industry to the region.
Recent Developments
In October 2022, Thermo Fisher Scientific launched a closed and automated cell isolation and bead removal solution to enhance the evolution of cell therapy manufacturing. This novel technology enhances cell purity and isolation efficiency, while also increasing the recovery of target cells for scalable cell therapy production.
In January 2022, Sony Corporation launched CGX10, an advanced cell isolation system that efficiently sorts cells at high speed and purity within a closed system.
In April 2019, Becton, Dickinson and Company (BD) released BD BACTEC platelet quality control media, enabling microbiology laboratories, blood banks, and transfusion services to identify contaminated platelet units.
Key Market Players
- Becton, Dickinson & Company
- Merck KGaA (Millipore Sigma)
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Terumo Corporation
- PluriSelect Life Science UG & Co. KG
- Danaher Corporation (Cytiva)
- STEMCELL Technologies Inc.
- Corning Inc.
- Akadeum Life Sciences Inc.
| By Product | By Cell Type | By Source | By Technique | By Application | By End User | By Region |
| |
| Consumables Instruments | Human Cells Animal Cells | Bone Marrow Cord Blood/Embryonic Stem Cells Adipose Tissue | Centrifugation-Based Cell Isolation Surface Marker-Based Cell Isolation Filtration-Based Cell Isolation | Biomolecule Isolation Cancer Research Stem Cell Research In Vitro Diagnostic Others | Biotechnology and Biopharmaceutical Companies Research Laboratories and Institutes Hospitals and Diagnostic Laboratories Cell Banks | North America Europe Asia Pacific South America Middle East & Africa | |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy